Elanco: Performance, Capabilities, Goals and Strategies in the Worldwide Animal Health Market
Global PDF: US$ 3,900.00
A strategic assessment of Elanco/Eli Lilly, one of the world’s leading animal health companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global animal health market.
Contains 25 pages and 3 tables
A strategic assessment of Elanco/Eli Lilly, one of the world’s leading animal health companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global animal health market.
Contains 25 pages and 3 tables
I. BUSINESS ORGANIZATION
II. SENIOR MANAGEMENT
III. FACILITIES AND EMPLOYEES
IV. TECHNOLOGICAL KNOW-HOW
V. PRODUCT PORTFOLIO
VI. MARKETING TACTICS
VII. SALES AND PROFIT GROWTH
VIII. R&D EXPENDITURES AND MAJOR PROGRAMS
IX. COLLABORATIVE ARRANGEMENTS
X. STRATEGIC DIRECTION
LIST OF TABLES
Table 1: Eli Lilly/Elanco Sales by Business Segment
Table 2: Eli Lilly/Elanco Sales Growth by Business Segment
Table 3: Eli Lilly/Elanco Animal Health Sales By Geographic Region
II. SENIOR MANAGEMENT
III. FACILITIES AND EMPLOYEES
IV. TECHNOLOGICAL KNOW-HOW
V. PRODUCT PORTFOLIO
VI. MARKETING TACTICS
VII. SALES AND PROFIT GROWTH
VIII. R&D EXPENDITURES AND MAJOR PROGRAMS
IX. COLLABORATIVE ARRANGEMENTS
X. STRATEGIC DIRECTION
LIST OF TABLES
Table 1: Eli Lilly/Elanco Sales by Business Segment
Table 2: Eli Lilly/Elanco Sales Growth by Business Segment
Table 3: Eli Lilly/Elanco Animal Health Sales By Geographic Region